{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T00:34:34Z","timestamp":1793579674000,"version":"4.5.0"},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>While cardiac magnetic resonance (CMR) provides prognostic value in transthyretin cardiac amyloidosis (ATTR-CA), current ATTR-CA staging relies on serum biomarkers. We evaluated the incremental value of incorporating CMR parameters into the National Amyloidosis Centre (NAC) staging and assessed their utility in guiding evaluation for advanced heart failure (HF) therapies and emerging disease-modifying treatments.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>We retrospectively analyzed a multicentre cohort of 266 ATTR-CA patients who underwent CMR between 2007 and 2023. Cox regressions were used to assess time to death. A baseline model was constructed using the NAC stage. CMR predictor variables were selected a priori based on clinical relevance and non-collinearity, then refined using stepwise backward elimination regression with NAC stage control; variables retained in \u2265 60% of 1000 bootstrapped samples were included. Internal validation was performed via bootstrapping, with performance reported as Harrell\u2019s C-statistic and calibration slope. Decision curve analysis evaluated clinical utility. A total of 85 patients (32%) died over a median follow-up of 20 months (IQR 8\u201335). Extracellular volume (ECV \u2265 59%, HR 2.45, 95% CI 1.2\u20135.2, P = 0.020) and indexed left atrial volume (LAVi \u2265 54 mL\/m2, HR 2.00, 95% CI 1.1\u20133.7, P = 0.026) were independently associated with mortality after NAC adjustment and improved prognostic accuracy across all biomarker stages. When risk prediction was framed around initiation of advanced HF or emerging disease-modifying therapies, incorporating CMR alongside NAC staging facilitated identification of 28 additional high-risk patients per 1000.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>CMR-derived ECV and LAVi were associated with incremental prognostic value in ATTR-CA beyond biomarker staging and may inform clinical risk stratification.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ehjci\/jeag170","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T20:37:43Z","timestamp":1782851863000},"page":"1603-1612","source":"Crossref","is-referenced-by-count":1,"title":["Incremental prognostic value of cardiac magnetic resonance beyond biomarker staging in transthyretin cardiac amyloidosis"],"prefix":"10.1093","volume":"27","author":[{"given":"Tommy","family":"Chiou","sequence":"first","affiliation":[{"name":"Division of Cardiovascular Medicine, The University of Chicago Medicine , 5758 South Maryland Avenue, M.C. 9067, Chicago, IL 60637 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iva","family":"Minga","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, The University of Chicago Medicine , 5758 South Maryland Avenue, M.C. 9067, Chicago, IL 60637 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varun","family":"Subashchandran","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, The University of Chicago Medicine , 5758 South Maryland Avenue, M.C. 9067, Chicago, IL 60637 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiane C","family":"Singulane","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, The University of Virginia Health System , Charlottesville, VA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit R","family":"Patel","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, The University of Virginia Health System , Charlottesville, VA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina M","family":"Zareba","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, The Ohio State University Wexner Medical Center , Columbus, OH ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin","family":"Lu","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, The Ohio State University Wexner Medical Center , Columbus, OH ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akash","family":"Goyal","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, The Ohio State University Wexner Medical Center , Columbus, OH ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jai","family":"Singh","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Atrium Health , Charlotte, NC ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D","family":"Elliott","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Atrium Health , Charlotte, NC ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidya","family":"Nadig","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Hartford HealthCare , Hartford, CT ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Fernandes","sequence":"additional","affiliation":[{"name":"Heart Institute (InCor), S\u00e3o Paulo University Medical School , S\u00e3o Paulo ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo L","family":"Vieira","sequence":"additional","affiliation":[{"name":"Heart Institute (InCor), S\u00e3o Paulo University Medical School , S\u00e3o Paulo ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9553-7641","authenticated-orcid":false,"given":"Shaimaa","family":"Fadl","sequence":"additional","affiliation":[{"name":"Division of Radiology, Virginia Commonwealth University , Richmond, VA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cory","family":"Trankle","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Virginia Commonwealth University , Richmond, VA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6179-2393","authenticated-orcid":false,"given":"Dipan J","family":"Shah","sequence":"additional","affiliation":[{"name":"Houston Methodist DeBakey Heart & Vascular Center , Houston, TX ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0274-7653","authenticated-orcid":false,"given":"El-Moatasem","family":"Gabr","sequence":"additional","affiliation":[{"name":"Houston Methodist DeBakey Heart & Vascular Center , Houston, TX ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Poonawalla","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, The University of Chicago Medicine , 5758 South Maryland Avenue, M.C. 9067, Chicago, IL 60637 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franklin","family":"Miralles","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, The University of Chicago Medicine , 5758 South Maryland Avenue, M.C. 9067, Chicago, IL 60637 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitasha","family":"Sarswat","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, The University of Chicago Medicine , 5758 South Maryland Avenue, M.C. 9067, Chicago, IL 60637 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5616-8839","authenticated-orcid":false,"given":"Amit","family":"Pursnani","sequence":"additional","affiliation":[{"name":"Endeavor Health Division of Cardiology, , Evanston, IL ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hena","family":"Patel","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, The University of Chicago Medicine , 5758 South Maryland Avenue, M.C. 9067, Chicago, IL 60637 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karima","family":"Addetia","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, The University of Chicago Medicine , 5758 South Maryland Avenue, M.C. 9067, Chicago, IL 60637 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2327-4544","authenticated-orcid":false,"given":"Jeremy","family":"Slivnick","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, The University of Chicago Medicine , 5758 South Maryland Avenue, M.C. 9067, Chicago, IL 60637 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"key":"2026090105474214600_jeag170-B1","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jacc.2022.11.022","article-title":"2023 ACC expert consensus decision pathway on comprehensive multidisciplinary care for the patient with cardiac amyloidosis: a report of the American College of Cardiology Solution Set Oversight Committee","volume":"81","author":"Kittleson","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"2026090105474214600_jeag170-B2","first-page":"102","article-title":"A systematic review and meta-analysis of the prevalence of transthyretin amyloidosis in heart failure with preserved ejection fraction","volume":"12","author":"Magdi","year":"2022","journal-title":"Am J Cardiovasc Dis"},{"key":"2026090105474214600_jeag170-B3","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10741-024-10444-4","article-title":"Contextualizing the results of HELIOS-B in the broader landscape of clinical trials for the treatment of transthyretin cardiac amyloidosis","volume":"30","author":"Girard","year":"2025","journal-title":"Heart Fail Rev"},{"key":"2026090105474214600_jeag170-B4","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1056\/NEJMoa2303765","article-title":"Phase 1 trial of antibody NI006 for depletion of cardiac transthyretin amyloid","volume":"389","author":"Garcia-Pavia","year":"2023","journal-title":"N Engl J Med"},{"key":"2026090105474214600_jeag170-B5","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJMoa2107454","article-title":"CRISPR-Cas9 In vivo gene editing for transthyretin amyloidosis","volume":"385","author":"Gillmore","year":"2021","journal-title":"N Engl J Med"},{"key":"2026090105474214600_jeag170-B6","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1093\/eurheartj\/ehx589","article-title":"A new staging system for cardiac transthyretin amyloidosis","volume":"39","author":"Gillmore","year":"2018","journal-title":"Eur Heart J"},{"key":"2026090105474214600_jeag170-B7","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.jacc.2016.06.033","article-title":"Natural history of wild-type transthyretin cardiac amyloidosis and risk stratification using a novel staging system","volume":"68","author":"Grogan","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2026090105474214600_jeag170-B8","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1161\/CIRCULATIONAHA.115.016567","article-title":"Prognostic value of late gadolinium enhancement cardiovascular magnetic resonance in cardiac amyloidosis","volume":"132","author":"Fontana","year":"2015","journal-title":"Circulation"},{"key":"2026090105474214600_jeag170-B9","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jacc.2017.05.053","article-title":"Magnetic resonance in transthyretin cardiac amyloidosis","volume":"70","author":"Martinez-Naharro","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2026090105474214600_jeag170-B10","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jcmg.2018.02.006","article-title":"Native T1 and extracellular volume in transthyretin amyloidosis","volume":"12","author":"Martinez-Naharro","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026090105474214600_jeag170-B11","doi-asserted-by":"crossref","first-page":"oead092","DOI":"10.1093\/ehjopen\/oead092","article-title":"Prognosis prediction in cardiac amyloidosis by cardiac magnetic resonance imaging: a systematic review with meta-analysis","volume":"3","author":"Boretto","year":"2023","journal-title":"Eur Heart J Open"},{"key":"2026090105474214600_jeag170-B12","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.jcmg.2018.02.016","article-title":"Cardiac structural and functional consequences of amyloid deposition by cardiac magnetic resonance and echocardiography and their prognostic roles","volume":"12","author":"Knight","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026090105474214600_jeag170-B13","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12968-018-0478-3","article-title":"Myocardial native T2 measurement to differentiate light-chain and transthyretin cardiac amyloidosis and assess prognosis","volume":"20","author":"Ridouani","year":"2018","journal-title":"J Cardiovasc Magn Reson"},{"key":"2026090105474214600_jeag170-B14","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1016\/j.jacc.2018.03.536","article-title":"Myocardial edema and prognosis in amyloidosis","volume":"71","author":"Kotecha","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2026090105474214600_jeag170-B15","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1007\/s00330-014-3487-0","article-title":"Disadvantages of using the area under the receiver operating characteristic curve to assess imaging tests: a discussion and proposal for an alternative approach","volume":"25","author":"Halligan","year":"2015","journal-title":"Eur Radiol"},{"key":"2026090105474214600_jeag170-B16","doi-asserted-by":"crossref","first-page":"3946","DOI":"10.1002\/sim.6195","article-title":"How to interpret a small increase in AUC with an additional risk prediction marker: decision analysis comes through","volume":"33","author":"Baker","year":"2014","journal-title":"Stat Med"},{"key":"2026090105474214600_jeag170-B17","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1001\/jama.2024.0442","article-title":"Cardiac amyloidosis due to transthyretin protein: a review","volume":"331","author":"Ruberg","year":"2024","journal-title":"JAMA"},{"key":"2026090105474214600_jeag170-B18","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12968-016-0321-7","article-title":"The global cardiovascular magnetic resonance registry (GCMR) of the society for cardiovascular magnetic resonance (SCMR): its goals, rationale, data infrastructure, and current developments","volume":"19","author":"Kwong","year":"2017","journal-title":"J Cardiovasc Magn Reson"},{"key":"2026090105474214600_jeag170-B19","doi-asserted-by":"crossref","first-page":"247","DOI":"10.7326\/0003-4819-145-4-200608150-00004","article-title":"Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate","volume":"145","author":"Levey","year":"2006","journal-title":"Ann Intern Med"},{"key":"2026090105474214600_jeag170-B20","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.jaccao.2020.06.007","article-title":"Diuretic dose and NYHA functional class are independent predictors of mortality in patients with transthyretin cardiac amyloidosis","volume":"2","author":"Cheng","year":"2020","journal-title":"JACC CardioOncol"},{"key":"2026090105474214600_jeag170-B21","article-title":"ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: part 1 of 2-evidence base and standardized methods of imaging","volume":"14","author":"Dorbala","year":"2021","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026090105474214600_jeag170-B22","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1532-429X-15-92","article-title":"Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement","volume":"15","author":"Moon","year":"2013","journal-title":"J Cardiovasc Magn Reson"},{"key":"2026090105474214600_jeag170-B23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12968-020-00607-1","article-title":"Standardized cardiovascular magnetic resonance imaging (CMR) protocols: 2020 update","volume":"22","author":"Kramer","year":"2020","journal-title":"J Cardiovasc Magn Reson"},{"key":"2026090105474214600_jeag170-B24","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1532-429X-13-16","article-title":"Myocardial extravascular extracellular volume fraction measurement by gadolinium cardiovascular magnetic resonance in humans: slow infusion versus bolus","volume":"13","author":"Schelbert","year":"2011","journal-title":"J Cardiovasc Magn Reson"},{"key":"2026090105474214600_jeag170-B25","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1136\/heartjnl-2014-305538","article-title":"Prognostic implications of global LV dysfunction: a systematic review and meta-analysis of global longitudinal strain and ejection fraction","volume":"100","author":"Kalam","year":"2014","journal-title":"Heart"},{"key":"2026090105474214600_jeag170-B26","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jcmg.2017.11.017","article-title":"Assessment of left ventricular function by echocardiography: the case for routinely adding global longitudinal strain to ejection fraction","volume":"11","author":"Potter","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026090105474214600_jeag170-B27","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000250","article-title":"A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score","volume":"2","author":"Singer","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"2026090105474214600_jeag170-B28","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.csda.2010.11.023","article-title":"Exact confidence interval estimation for the Youden index and its corresponding optimal cut-point","volume":"56","author":"Lai","year":"2012","journal-title":"Comput Stat Data Anal"},{"key":"2026090105474214600_jeag170-B29","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1001\/jama.2017.12126","article-title":"Discrimination and calibration of clinical prediction models: users\u2019 guides to the medical literature","volume":"318","author":"Alba","year":"2017","journal-title":"JAMA"},{"key":"2026090105474214600_jeag170-B30","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1177\/0272989X06295361","article-title":"Decision curve analysis: a novel method for evaluating prediction models","volume":"26","author":"Vickers","year":"2006","journal-title":"Med Decis Making"},{"key":"2026090105474214600_jeag170-B31","doi-asserted-by":"crossref","first-page":"i88","DOI":"10.1093\/eurheartjsupp\/suae111","article-title":"Cardiac amyloidosis: innovations in diagnosis and treatment","volume":"27","author":"Castiglione","year":"2025","journal-title":"Eur Heart J Suppl"},{"key":"2026090105474214600_jeag170-B32","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1056\/NEJMoa2300757","article-title":"Patisiran treatment in patients with transthyretin cardiac amyloidosis","volume":"389","author":"Maurer","year":"2023","journal-title":"N Engl J Med"},{"key":"2026090105474214600_jeag170-B33","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1056\/NEJMc2501792","article-title":"Vutrisiran in patients with transthyretin amyloidosis with cardiomyopathy","volume":"392","author":"Zaidan","year":"2025","journal-title":"N Engl J Med"},{"key":"2026090105474214600_jeag170-B34","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ijcard.2011.12.055","article-title":"Peak oxygen consumption and prognosis in heart failure: 14 mL\/kg\/min is not a \u201cgender-neutral\u201d reference","volume":"167","author":"Corr\u00e0","year":"2013","journal-title":"Int J Cardiol"},{"key":"2026090105474214600_jeag170-B35","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jclinepi.2015.04.005","article-title":"Prediction models need appropriate internal, internal-external, and external validation","volume":"69","author":"Steyerberg","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"2026090105474214600_jeag170-B36","volume-title":"Stata Statistical Software: Release 19","author":"StataCorp","year":"2025"},{"key":"2026090105474214600_jeag170-B37","first-page":"424","article-title":"Biomarkers and prediction of prognosis in transthyretin-related cardiac amyloidosis: direct comparison of two staging systems","volume":"36","author":"Cappelli","year":"2020","journal-title":"Can J Cardiol"},{"key":"2026090105474214600_jeag170-B38","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ijcard.2018.10.079","article-title":"High-sensitivity troponin T, NT-proBNP and glomerular filtration rate: a multimarker strategy for risk stratification in chronic heart failure","volume":"277","author":"Aimo","year":"2019","journal-title":"Int J Cardiol"},{"key":"2026090105474214600_jeag170-B39","doi-asserted-by":"crossref","first-page":"101568","DOI":"10.1016\/j.jacadv.2024.101568","article-title":"Accuracy of established prognostic staging systems for cardiac transthyretin amyloidosis in the tafamidis era","volume":"4","author":"Muller","year":"2025","journal-title":"JACC Adv"},{"key":"2026090105474214600_jeag170-B40","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/joim.12324","article-title":"Measurement of myocardial amyloid deposition in systemic amyloidosis: insights from cardiovascular magnetic resonance imaging","volume":"277","author":"Barison","year":"2015","journal-title":"J Intern Med"},{"key":"2026090105474214600_jeag170-B41","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.jcmg.2012.04.006","article-title":"Quantification of extracellular matrix expansion by CMR in infiltrative heart disease","volume":"5","author":"Mongeon","year":"2012","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026090105474214600_jeag170-B42","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/j.jacc.2019.01.059","article-title":"Left atrial structure and function, and left ventricular diastolic dysfunction: JACC state-of-the-art review","volume":"73","author":"Thomas","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2026090105474214600_jeag170-B43","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jcmg.2021.06.022","article-title":"Clinical importance of left atrial infiltration in cardiac transthyretin amyloidosis","volume":"15","author":"Bandera","year":"2022","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026090105474214600_jeag170-B44","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/j.jcmg.2021.01.016","article-title":"Prognostic utility of echocardiographic atrial and ventricular strain imaging in patients with cardiac amyloidosis","volume":"14","author":"Huntjens","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026090105474214600_jeag170-B45","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s41512-019-0064-7","article-title":"A simple, step-by-step guide to interpreting decision curve analysis","volume":"3","author":"Vickers","year":"2019","journal-title":"Diagn Progn Res"},{"key":"2026090105474214600_jeag170-B46","first-page":"359","article-title":"Left ventricular assist device in cardiac amyloidosis: friend or foe?","volume":"28","author":"Sciaccaluga","year":"2023","journal-title":"Heart Fail Rev"},{"key":"2026090105474214600_jeag170-B47","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.125.047135","article-title":"Temporal trends in incidence and prevalence of transthyretin amyloid cardiomyopathy in the United States","volume":"15","author":"Alexander","year":"2026","journal-title":"J Am Heart Assoc"},{"key":"2026090105474214600_jeag170-B48","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1093\/eurheartj\/ehz905","article-title":"Echocardiographic phenotype and prognosis in transthyretin cardiac amyloidosis","volume":"41","author":"Chacko","year":"2020","journal-title":"Eur Heart J"},{"key":"2026090105474214600_jeag170-B49","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1161\/CIRCULATIONAHA.118.038169","article-title":"Natural history, quality of life, and outcome in cardiac transthyretin amyloidosis","volume":"140","author":"Lane","year":"2019","journal-title":"Circulation"}],"container-title":["European Heart Journal - Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/advance-article-pdf\/doi\/10.1093\/ehjci\/jeag170\/68663575\/jeag170.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/article-pdf\/27\/9\/1603\/68663575\/jeag170.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/article-pdf\/27\/9\/1603\/68663575\/jeag170.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T09:48:10Z","timestamp":1788256090000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/article\/27\/9\/1603\/8722781"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":49,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,7,1]]},"published-print":{"date-parts":[[2026,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjci\/jeag170","relation":{},"ISSN":["2047-2404","2047-2412"],"issn-type":[{"value":"2047-2404","type":"print"},{"value":"2047-2412","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,7,1]]}}}